StreetInsider.com News Articles

Form 4 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna

Wed, 17 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260617/26660231.html

Form 4 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna

Wed, 17 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260617/26660231.html

Form 3 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna

Wed, 17 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260617/26660194.html

Form 3 Ovid Therapeutics Inc. For: Jun 15 Filed by: Greka Anna

Wed, 17 Jun 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260617/26660194.html

Form 8-K Ovid Therapeutics Inc. For: Jun 11

Thu, 11 Jun 2026 09:03:00 -0400

si-local-file:///var/storage/secattach/20260611/26633489.html

Form 8-K Ovid Therapeutics Inc. For: Jun 11

Thu, 11 Jun 2026 09:03:00 -0400

si-local-file:///var/storage/secattach/20260611/26633489.html

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Thu, 04 Jun 2026 07:00:00 -0400

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today announced that the Company’s management will participate in two upcoming investor conferences:

Oppenheimer CNS & Neuro-Muscular Summit – Wednesday, June 10 at 3:45 pm ET
H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference – Monday, June 15

A webcast of the presentations can be accessed through the Events & Presentations section of the company’s website at investors.ovidrx.com. An archived

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Thu, 04 Jun 2026 07:00:00 -0400

Oppenheimer CNS & Neuro-Muscular Summit – Wednesday, June 10 at 3:45 pm ET
H.C. Wainwright 7th Annual Neuro Perspectives Hybrid Conference – Monday, June 15

A webcast of the presentations can be accessed through the Events & Presentations section of the company’s website at investors.ovidrx.com. An archived

Form 8-K Ovid Therapeutics Inc. For: May 29

Wed, 03 Jun 2026 07:03:00 -0400

si-local-file:///var/storage/secattach/20260603/26595290.html

Form 8-K Ovid Therapeutics Inc. For: May 29

Wed, 03 Jun 2026 07:03:00 -0400

si-local-file:///var/storage/secattach/20260603/26595290.html

Ovid Therapeutics names Anna Greka to board of directors

Wed, 03 Jun 2026 07:00:16 -0400

Ovid Therapeutics Inc. (NASDAQ: OVID) announced the appointment of Anna Greka, M.D., Ph.D., to its board of directors, effective June 15, 2026.

Greka serves as a core institute member at the Broad Institute of MIT and Harvard and is a professor of medicine at Harvard Medical School and Mass General Brigham. She currently leads the Ladders to Cures Scientific Accelerator, an organization focused on translating fundamental discoveries into therapies.

The physician-scientist has founded and advised multiple biotechnology companies, including Goldfinch Bio, which was acquired by Bristol Myers Squibb, and a company recently acquired by AstraZeneca. She holds over 25 years of experience

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Wed, 03 Jun 2026 07:00:00 -0400

NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today announced the appointment of Anna Greka, M.D., Ph.D., to its Board of Directors, effective June 15, 2026.

“Anna is a visionary, passionate physician-scientist and entrepreneur whose work sits at the intersection of groundbreaking nodal biology and therapeutic innovation,” said Meg Alexander, President and Chief Executive Officer, Ovid Therapeutics. “Her pioneering work in ion channel biology has fundamentally advanced our understanding of disease biology and enabled

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Wed, 03 Jun 2026 07:00:00 -0400

Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.

Fri, 15 May 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26506274.html

Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Point72 Asset Management, L.P.

Fri, 15 May 2026 16:29:00 -0400

si-local-file:///var/storage/secattach/20260515/26506274.html

Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Fri, 15 May 2026 11:58:00 -0400

si-local-file:///var/storage/secattach/20260515/26502479.html

Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC

Fri, 15 May 2026 11:58:00 -0400

si-local-file:///var/storage/secattach/20260515/26502479.html

Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Sirenia Capital Management LP

Fri, 15 May 2026 08:03:00 -0400

si-local-file:///var/storage/secattach/20260515/26499827.html

Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: Sirenia Capital Management LP

Fri, 15 May 2026 08:03:00 -0400

si-local-file:///var/storage/secattach/20260515/26499827.html

Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.

Fri, 15 May 2026 06:32:00 -0400

si-local-file:///var/storage/secattach/20260515/26498921.html

Form SCHEDULE 13G Ovid Therapeutics Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.

Fri, 15 May 2026 06:32:00 -0400

si-local-file:///var/storage/secattach/20260515/26498921.html

Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: LEVIN JEREMY M

Thu, 14 May 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260514/26495601.html

Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: LEVIN JEREMY M

Thu, 14 May 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260514/26495601.html

Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC

Thu, 14 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260514/26495316.html

Form SCHEDULE 13G/A Ovid Therapeutics Inc. Filed by: Affinity Asset Advisors, LLC

Thu, 14 May 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20260514/26495316.html